REMSleep Holdings, developer of the DeltaWave nasal pillow system, has received expanded 510(k) clearance from the U.S. Food ...

Respiratory and sleep medicine physicians share collaborative measures to diagnose and treat comorbid sleep disorders and ...

A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could transform treatment for millions struggling with device therapies.

Sleep apnea is increasingly common in India, yet few seek help. Factors like pollution and urban stress worsen sleep quality, leading to serious health risks.

Naturepedic reports that snoring affects many adults, leading to sleep issues. They offer natural remedies and sleep hygiene ...

Are you tossing and turning at night or noticing a loved one acting strange once the sun goes down? Doctors are finding that ...

Sleep technology is moving beyond tracking, as device makers and health groups focus on shaping sleep, writes ARTHUR GOLDSTUCK.

Supplemental Clearance Opens Institutional Markets and Expands Patient Population Beyond Traditional CPAP Therapy BLACKSHEAR, GA - January 15, 2026 (NEWMEDIAWIRE) - REMSleep Holdings, Inc. (OTCQB: ...

ResMed is betting big on artificial intelligence (AI) to boost CPAP adherence. At the recent J.P. Morgan Healthcare Conference, CEO Mick Farrell said the company’s first AI-enabled medical device, Sma ...

With the feel of a high-end spa or hotel, the new Mercy Health Boardman Sleep Medicine Center is ready to welcome patients ...

According to Johns Hopkins Medicine, 45% of adults snore at least occasionally, and a quarter of all adults snore regularly.

The expanded 510 (k) clearance is publicly available in the FDA's 510 (k) Premarket Notification database under device number K253939.